Prevalence Of Female Sexual Dysfunction Research Articles

Prevalence and risk factors of female sexual dysfunction in low-risk women attending gynecology clinic at Kasr Alainy hospital: a cross-sectional study

Background: In Egypt, research on female sexual dysfunction, a prevalent health issue, is insufficient. Sexual dysfunction can develop later in life following a period of normal sexual functioning, or it can be an issue from the beginning of sexual activity. Objective: The purpose of this research is to determine the prevalence of female sexual dysfunction and to look into potential risk factors that could lead to it in Egyptian women. Methodology: This cross-sectional clinic-based survey trial was carried out at the Kasr Alainy gynecology outpatient clinic. 400 women were enrolled in the research after giving their consent, and data was gathered using a structured questionnaire, in which each participant was asked the same questions in the same sequence and manner throughout the interview. The validated Arabic version of the World Health Organization Quality of Life Questionnaire-Brief, which was provided by female investigators, was given to the participants to complete. Results: Prevalence of female sexual dysfunction was 63% (252 females). Sexual dysfunction was statistically significantly higher among women aged between 35-45 years, with low educational level, no occupation, cases with low family income, residents of rural areas and duration of marriage >10 years. We noted highly statistically significant association between sexual dysfunction and nullipara, previous episiotomy, repeated CS, circumcision and no contraception and vaginitis or cervicitis. Conclusion: Two thirds of women who visited the Kasr Alainy Hospital's gynecological outpatient clinic had female sexual dysfunction, a serious health issue that affected their quality of life.

(174) Sexual Dysfunction and Coping Mechanisms among Women Using Hormonal Contraceptives at Kawempe Hospital - A Cross-Sectional Study

Abstract Introduction Sexual dysfunction is a significant problem among women, and it is associated with maladaptive coping mechanisms that can further worsen the situation. In African regions, the prevalence of female sexual dysfunction (FSD) is highly linked to hormonal contraceptives (HCs), a popular method of birth control. Uganda has a relatively high prevalence of HC use among women of reproductive age. However, there is limited research on sexual dysfunction and coping mechanisms among women who use HCs in Kawempe Hospital. Objective This study aimed to (1) estimate the prevalence of sexual dysfunction among women who use hormonal contraceptives, (2) describe the coping mechanisms used by women who use hormonal contraceptives, and (3) identify the sociodemographic and clinical characteristics associated with sexual dysfunction among women using hormonal contraceptives at Kawempe Hospital. Methods This was a cross-sectional study where sexually active adult females who were on hormonal contraceptives and gave informed consent were consecutively sampled. The female sexual function index and the SexFlex scale were used to assess sexual dysfunction and coping mechanisms of women using hormonal contraceptives. Means, proportions, chi squares and logistic regression were used to describe the population and determine characteristics associated with sexual dysfunction. Results Of the 401 participants recruited for the study, 386 were analyzed due to 15 incomplete questionnaires. The average age of participants was 29.4 years. Of the participants, almost half 46.6% used implants. The prevalence of FSD was 74.6%. Participants with FSD reported more reflexive 82 (28.47%) and less approach coping 62 (21.53%) than participants without FSD. Factors associated with FSD were relationship dissatisfaction (OR=3.78, 95% CI: 1.68, 8.5), psychological distress (OR=2.12, 95% CI: 1.17, 3.86), finding sex important (OR=0.22, 95%CI: 0.05, 0.88) and approach coping mechanisms (OR=0.49, 95%CI: 0.26, 0.95). FSD was not significantly associated with HCs Conclusions This study found that women HCs have a high prevalence of FSD that is associated with psychological factors such as relationship dissatisfaction and psychological distress. The study suggests that women using HCs should be regularly screened for FSD and that clinicians should help them find solutions to the underlying causes. Disclosure No.

(184) The Prevalence of Sexual Dysfunction in Women Seeking Infertility Treatment in Vietnam

Abstract Introduction Sexual function plays a crucial role in women's psychosocial and overall well-being, significantly impacting their quality of life. Any decline in sexual function can have detrimental effects on the affected individuals' quality of life Objective (i) To describe the prevalence of sexual dysfunction in women seeking infertility treatment at the Andrology and Fertility Hospital of Hanoi, Viet Nam, and (ii) to analyze the factors associated with sexual dysfunction in the study population. Methods This was a cross-sectional descriptive study. All women (1.039) seeking infertility treatment at the Andrology and Fertility Hospital from December 30, 2022, to March 30, 2023 participate in the study. They were invited to scan a QR code and complete the research questionnaire. Female sexual dysfunction is assessed based on the FSFI scale included six domains: sexual desire, arousal, lubrication, orgasm, satisfaction, and pain (comprising 19 questions). The data were extracted into Excel, cleaned, and analyzed using STATA 17.0 software. The analysis of factors associated with female sexual dysfunction was conducted using logistic regression models. Results Among the 1039 participants in the study, the mean age was 30.9±5.3 years. The overall score for female sexual dysfunction was 25.09 ± 6.20, with individual component scores. The prevalence of female sexual dysfunction was 49.7%. There is a positive correlation among the six components of female sexual dysfunction, p<0.01. In the multivariate regression model, the risk of female sexual dysfunction is higher among individuals who work away from home, have an underweight body mass index, have a poor relationship with their partner, have had no sexual intercourse in the past 4 weeks, experience fear of pain, anxiety, and body image concerns during sexual activity, have infrequent or no discussions with their partner regarding sexual desires, preferred positions, and stimulation, and are dissatisfied with their sexual life. Conclusions Half of the women seeking infertility in late-stage medical care experience sexual dysfunction. Factors that increase the risk of sexual dysfunction include having a job far from home, being underweight based on body mass index, having a poor overall relationship with a partner, not engaging in sexual activity in the past four weeks, fear of pain, anxiety, body image concerns during sexual intercourse, and limited or lack of communication with a partner about sexual issues such as desires, preferred positions, and stimulation. Additionally, dissatisfaction with one's sexual life contributes to the occurrence of sexual dysfunction. Therefore, early screening and timely intervention are necessary for this group of individuals. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Andrology and Fertility Hospital of Hanoi.

(181) Female Sexuality During the Menopausal Transition: The Experience of Tunisian women

Abstract Introduction The menopausal transition is a gradual passage from pre-menopause to menopause. It is characterized by hormonal changes that affect a woman's reproductive and sexual health. Understanding the impact of the menopausal transition on sexual functioning is important for providing comprehensive care to these women. Objective Objective: In this study, we aimed to evaluate female sexuality in middle-aged Tunisian women using the female sexual function index (FSFI) Methods This was a descriptive and analytic transversal study, conducted at the Hammam-Lif sexual and reproductive health center over a period of 06 months from February 1st to July 31st, 2022. We included 162 women aged between 40 and 65 years old. We used a validated Arabic version of the Female Sexual Function Index to assess female sexual function. Results The average age of women included in our study was 48.27 years. The majority of questioned women were peri-menopausal, i.e. 40.74%, 35.8% were in pre-menopause and 23.6% were in post-menopause. Moreover, among postmenopausal women, only one patient took hormone replacement therapy. The mean gestity was 3.6 and mean parity was 2.5 in our study population. The majority of women had a gestation greater than or equal to three [0 to 8] and a parity greater than or equal to 2 [0 to 8], i.e. in 80.25% of cases. The mean FSFI score was 18.83 ±7.19, with extremes ranging from 2 to 30.4. The prevalence of sexual dysfunction in our study was as high as 88.9 %. The analysis of our results showed a degradation of the FSFI score from perimenopause to postmenopausal: it went from 21.21±6.4 in pre-menopause, to 18.56±7.33 in perimenopause and 15.65±7.11 in postmenopausal. The difference between the three periods was statistically significant (p=0.030). This decline was statistically significant for three domains namely desire (p=0.033), arousal (p=0.047), and orgasm (p<0.01). Conclusions The prevalence of female sexual dysfunction is quite high and tends to increase with age. The role of healthcare professionals is essential in caring for women and helping them overcome sexual health problems that arise during the menopausal transition period. Disclosure No.

(179) Sexual Dysfunctions in Infertile Tunisian Women

Abstract Introduction Once perceived as a source of pleasure and enjoyment, sexuality has evolved for infertile couples, focusing primarily on a purely procreative objective. Infertility has a direct impact on a woman's sex life, calling into question her femininity and causing significant alterations in the components of her sexual response. Objective The aims of our study were to assess the frequency of sexual dysfunction in Tunisian women facing infertility and to identify the aspects of their sexuality most affected. Methods This was a prospective, cross-sectional, and descriptive study, including a sample of 200 Tunisian infertile women, followed up in a Tunisian Assisted reproduction center over a three-month period, from November 24, 2022 to February 24, 2023. To assess the different dimensions of sexuality in infertile women, we used the Arabic version of the FSFI (female sexual function index) Results The mean age of our women was 30 ± 4 years. The majority had a university educational level (80%), an urban origin (87%), an average socio-economic level (63%), and no medical or gynecological surgery history (62%). Most partners (67%) had no sexual dysfunction (SD). The most frequent male SD was premature ejaculation, observed in 14% of cases. As regards the etiology of infertility, most cases were classified as unexplained (28%), while the remainder were linked to female causes, dominated by PCOS (40%). The majority of women had initially discussed the subject of sexuality (72%) with their partners. In our sample, the mean FSFI score was 20.74, with extremes ranging from 2 to 35.4. The prevalence of female sexual dysfunction (FSD) was 82%. The areas most affected were sexual satisfaction (50%), reaching orgasm (45%), as well as lubrication (44%) and arousal (44%). Lower educational level, secondary infertility, contraceptive use, and a long history of fertility treatment as well as the presence of sexual dysfunction in the male partner, were found to be associated with sexual dysfunction in women suffering from infertility, yet no significant correlation was established. Conclusions Infertility is associated with high rates of sexual dysfunction. Thorough counseling and continuing support of infertile women is therefore indicated. Disclosure No.

(027) The Prevalence of Female Sexual Dysfunction in Patients with Irritable Bowel Syndrome (IBS)

Abstract Introduction Irritable bowel syndrome is a functional disorder in the digestive system that is defined by specific intestinal-gastric symptoms. A combination of psychological and organic causes are involved in its creation and continuation. A wide range of psychological disorders and personality traits have been reported in patients with irritable bowel syndrome; But one of the consequences and complications of this syndrome can be the effect on sexual performance. Objective In this study, the frequency of each of women's sexual dysfunction, including hypo active sexual desire and arousal disorder, orgasm dysfunction and pain during sex, and the level of satisfaction in sex were compared with the control group. The relationship between the severity of each of these sexual disorders and the severity of symptoms of irritable bowel syndrome has been investigated. Methods In this study 300 patients with irritable bowel syndrome presentation has compared with control group by using FSFI (Female Sexual Function-Index) standard questionnaire which its validity and reliability were assessed and demographic questionnaire. Results Examining the dimensions of sexual desire in two groups showed that the frequency and intensity of sexual stimulation and satisfaction with it in women with irritable bowel syndrome is significantly lower than the control group. The number of orgasms and intensity of orgasm experienced and satisfaction with it in women with irritable bowel syndrome is significantly lower than in the control group. Examining the dimensions of sexual satisfaction in two groups showed that the level of closeness with a sexual partner in women with irritable bowel syndrome is significantly lower than in the control group. Based on the results, there is a significant relationship between the score of sexual pleasure and sexual satisfaction and the severity of irritable bowel syndrome symptoms. Conclusions The results of this research showed that symptoms of irritable bowel syndrome can have significant effects on sexual performance and relationship satisfaction in women. Since women are exposed to more psychological stressors compared to men, and on the other hand, psychological factors can aggravate the symptoms of irritable bowel syndrome, the doctor's attention to sexual problems in women can improve the health and quality of life of affected patients. Disclosure No.

Female sexual function index for screening of female sexual dysfunction using DSM-5-TR criteria in Thai women: A prospective cross-sectional diagnostic study.

Thai Female Sexual Function Index discrimination using the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision criteria has not been investigated. This study aimed to evaluate the Female Sexual Function Index as a tool for assessing sexual symptoms and to determine the prevalence of female sexual dysfunction in Thai women using the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision criteria. This prospective cross-sectional diagnostic study included sexually active women aged ≥18 years, interviewed from January to June 2023. The participants completed the Thai version of a comprehensive of the Female Sexual Function Index questionnaire encompassing general information and self-reported assessments of female sexual function, followed by a semi-structured interview of distress symptom severity. Female sexual function was determined by screening of the total Female Sexual Function Index score, whereas female sexual dysfunction was evaluated using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision criteria. Using receiver operating characteristic curves, a clinical cutoff for the Female Sexual Function Index score of 23.1 was determined to identify female sexual dysfunction (area under the curve, 0.76; 95% confidence interval, 0.71-0.80; sensitivity, 75.6%; specificity, 67.7%; positive predictive value, 77.7%; negative predictive value, 65%). A prevalence of 40.2% for female sexual dysfunction was observed in the study population. The results of this study could be used as practical guidance for the screening of women affected by female sexual dysfunction in Thailand in the future.

Prevalence and associated factors of sexual dysfunction in female hemodialysis patients: first report from Somalia

BackgroundSexual dysfunction is frequent in female hemodialysis patients and is related to poorer quality of life. It is often a neglected topic associated with marked distress and interpersonal difficulties.ObjectiveFew studies are reported from Sub-Saharan African Countries (SSA) regarding female sexual dysfunction (FSD) in (HD) patients. The study aims to explore the prevalence and associated factors of FSD in female HD at a sole dialysis centre in Somalia.MethodOver a one-month period, a cross-sectional study was conducted among women with end-stage renal disease aged 18–50 years who were undergoing a dialysis program for at least three months at the dialysis center of our hospital. The participants were married, and they were living with their partners. Data regarding the sociodemographic features, clinical characteristics, frequency of sexual intercourse per week, and the Female Sexual Function Index (FSFI) scores were collected using a standard face-to-face interview questionnaire.ResultsDuring the study period, a total of 115 participants were eligible for the study’s inclusion criteria. The mean patient age was 38.5 ± 9.3 years. The most common cause of ESRD was diabetes, which accounted for 53%, followed by hypertension (26.1%) and glomerulonephritis (9.6%). The mean duration of dialysis was 2.9 ± 1.4 years, and approximately two-thirds of the participants (62.5%) were in the program for more than three years. Regarding the frequency of sexual intercourse, 61.7% of female participants performed sexual intercourse less than once time/a week. The prevalence of FSD was 92.2% (n = 106) of all participants. The mean FSFI score of the participants was 16.05 ± 4.48. Longer duration of dialysis program (i.e., more than four years), increasing age (i.e., > 35 years), those with diabetes had scored lower overall FSFI scores.ConclusionThe prevalence of female sexual dysfunction among Somali female hemodialysis patients was very high, representing a significant problem in end-stage renal disease (ESRD). Our study findings revealed that increasing age, diabetes, and duration of dialysis negatively impact female sexual function and are significantly associated with FSD.

The prevalence and risk factors of sexual dysfunction among females with inflammatory bowel disease: a systematic review and meta-analysis.

In recent years, numerous epidemiological studies have investigated the prevalence of female sexual dysfunction (FSD) in females with inflammatory bowel disease (IBD). However, a comprehensive systematic review with meta-analysis pooling their findings is lacking. This study aimed to determine the pooled prevalence estimates of FSD and its risk factors among females with IBD based on extensive research in electronic databases (PubMed, Embase, and Web of Science) from inception until April 1, 2023. The overall prevalence of FSD among females with IBD, along with its 95% confidence interval (CI), and subgroup-specific prevalence rates, were summarized. Sources of heterogeneity were identified through subgroup analyses and meta-regression. A total of 13 studies were included in this systematic review and meta-analysis. The pooled global prevalence of FSD among females with IBD was 61.4% (95% CI: 52.8-70.1%). Sensitivity analysis, which involved excluding individual studies, indicated no significant variation in the pooled prevalence, confirming the robustness of our results. Additionally, a significant risk factor for FSD among females with IBD was the quality of life (OR = 0.39, 95% CI: 0.19-0.79). In conclusion, our systematic review and meta-analysis revealed a high prevalence of FSD among females with IBD, which warrants attention from health organizations and clinical practitioners. Importantly, the quality of life was identified as a potential risk factor for FSD in this population. Nonetheless, future prospective cohort studies with a large sample size are warranted to confirm these findings.

Effect of chronic skin disease on female sexual function (FSF) among married Egyptian women

Background Female sexual dysfunction (FSD) is a term used to describe various sexual problems, such as low desire or interest, diminished arousal, orgasmic difficulties, and dyspareunia. Objectives The aim of the present study was to determine the effect of chronic skin disease on female sexual function among married Egyptian females as well as the prevalence of FSD among them and its effect on their husbands. Patients and methods The study was conducted on 300 sexually active married Egyptian women attending the Dermatology Outpatient Clinic of Minia University Hospital and Kom Elshokafa Clinic (Alexandria). All women were asked to fill out the female sexual function index sheet using the Arabic validated translated version of it. Those with FSD were asked about its effect on their husbands. Results We reported that 234 (78%) women with chronic skin disease had sexual dysfunction. Despite dysfunction being more common among those who had skin disease, compared with nondysfunction, it was not statistically significantly different among most skin diseases. There was a positive correlation between female’s age and percentage of dysfunction. It was found that only 15.9% of those with FSD showed an effect on their partners in the form of decreased libido. Limitations Limitations include the lack of a control group; the standardization of data, which may not be representative of the community, as they related to specific areas; and being a cross-sectional hospital-based study. Conclusion Our study revealed a high prevalence of FSD (78%) among Egyptian married women with chronic skin disease in both Minia and Kom Elshokafa (Alexandria) districts. However, it was not statistically significantly different among most skin diseases, with affection of only 15.9% of their partners.

Sexual Dysfunction in a Sample of Women Having Infertility and Its Impact on Quality of Life

Conflict of interest None of the above authors have any conflict of interest to disclose. Background Female sexual disorders are prevalent disorder which is underdiagnosed due to cultural barriers in seeking help in management, having huge impact on mental health quality of life. The studies investigating the impact of infertility on female sexual dysfunction are scarce, but they have consistently demonstrated that sexual complaints are very common among infertile women. Sometimes appropriate treatment of female sexual dysfunction can preclude the use of expensive and unnecessary treatment for infertility. This study will compare sexual dysfunction and quality of life among infertile women and fertile women. Aim of the Work To assess the female sexual function among infertile women and comorbid psychiatric disorders among infertile women. Subjects and method: This is cross sectional study, which was conducted on random sample of 168 infertile females and 167 fertile females, attending outpatient infertile clinic, and the gynaecology outpatient clinic, Ain Shams University hospital, the study started September 2017 until February 2019, all females who fulfil inclusion criteria were subjected to SCID-I, The Arabic version of (FSFI), The Arabic version of PCASEE. Results there was a statistically significant relationship between female sexual dysfunction among infertile group and fertile group, in the infertile group, 123 females (73.2%) of the infertile females did not have mental disorder and 45 females (26.7%) had mental disorder, 19 females (11.3%) of them had anxiety disorder (generalized anxiety disorder, social phobia, and panic disorder) and 26 females (15.5%) of them had major depression disorder. Conclusion There is high prevalence of female sexual dysfunction among the infertile female group, and there was strong association between infertility, sexual dysfunction and developing comorbid psychiatric disorder. Further assessments should be considered in the infertility clinic, proper documentation as well. Management should include psychotherapy, lubricants, targeted sexual-therapy and pharmacological treatment. Abbreviation SCID-I: Structured Clinical Interview for the DSM-IV Axis I Disorder; FSFI: Female sexual dysfunction index; PCASEE: Physical, cognitive, Affect, Social, economic, ego, quality of life

Sexual dysfunction among early-onset colorectal cancer survivors: Sex-specific correlates of sexual health discussions between patients and providers

PurposeTo examine the prevalence of female sexual dysfunction (FSD), male erectile dysfunction (ED), and the prevalence and correlates of sexual health discussions between early-onset CRC survivors and their health care providers.MethodsAn online, cross-sectional survey was administered in partnership with a national CRC advocacy organization. Respondents (n = 234; diagnosed < 50 years, 6–36 months from diagnosis/relapse) were colon (36.8%) and rectal (63.3%) cancer survivors (62.5% male). The Female Sexual Function Index (FSFI-6) was used to measure FSD, and the International Index of Erectile Function (IIEF-5) was used to measure ED. Survivors reported whether a doctor communicated with them about sexual issues during/after treatment.ResultsAmong females (n = 87), 81.6% had FSD (mean FSFI-6 score = 14.3 [SD±6.1]). Among males (n = 145), 94.5% had ED (mean IIEF-5 score = 13.6 [SD±3.4]). Overall, 59.4% of males and 45.4% of females reported a sexual health discussion. Among the total sample, older age of diagnosis and relapse were significantly associated with reporting a discussion, while female sex was negatively associated with reporting a sexual health discussion. Among males, older age at diagnosis and relapse, and among females, older age of diagnosis, were significantly associated with reporting a sexual health discussion.ConclusionThe prevalence of FSD and ED were high (8 in 10 females reporting FSD, almost all males reporting ED), while reported rates of sexual health discussion were suboptimal (half reported discussion). Interventions to increase CRC provider awareness of patients at risk for not being counseled are needed to optimize long-term health outcomes.

Prevalence and predictors of sexual dysfunction in females with type 1 diabetes: a systematic review and meta-analysis.

Several observational studies have explored the prevalence and predictors of female sexual dysfunction (FSD) among females with type 1 diabetes. However, no systematic review and meta-analysis of pooled data provide reliable estimates of FSD prevalence among females with type 1 diabetes. To investigate the global prevalence of FSD, analyze the association between FSD risk and type 1 diabetes, and evaluate the predictors of FSD among females with type 1 diabetes. The study search of the present systematic review was conducted through the Wanfang Database, China National Knowledge Infrastructure, PubMed, and Embase from the inception date to February 28, 2023. Heterogeneity among the studies was analyzed with the Q and I2 tests. The sources of heterogeneity were detected through subgroup analyses and meta-regression. Outcomes included the pooled prevalence of FSD among females with type 1 diabetes, the association between FSD risk and type 1 diabetes, and the predictors of FSD among females with type 1 diabetes. The pooled prevalence of FSD among females with type 1 diabetes was 38.5% (95% CI, 32.1%-45.0%). The risk of FSD was higher in patients with type 1 diabetes than in healthy controls (odds ratio [OR],3.77; 95% CI, 2.24-6.35). The significant predictors of FSD among females with type 1 diabetes were depression status (OR,2.77; 95% CI, 1.29-5.93) and longer diabetes duration (OR,1.19; 95% CI, 1.06-1.34). Females with type 1 diabetes had a significantly increased prevalence of FSD, indicating that clinicians should be concerned about FSD among females with type 1 diabetes. The strength of the present study is that it is the first systematic review and meta-analysis to investigate the global prevalence and predictors of FSD among females with type 1 diabetes. The limitation is that the results revealed significant heterogeneity after pooling the articles. The present systematic review and meta-analysis revealed that the overall prevalence of FSD among females with type 1 diabetes was 38.5%, demonstrating a significant association between FSD risk and type 1 diabetes among females. Furthermore, we found that the significant predictors for FSD among females with type 1 diabetes were depression and a longer duration of diabetes.

Prevalence of Female Sexual Dysfunction Among Psoriatic Females: A Cross Sectional Case Controlled Study.

Sexual relationships are an integral part of females psychological and physiological wellbeing. The study aimed to identify prevalence and impact of Female Sexual Dysfunction (FSD) in women affected with psoriasis. This cross-sectional study was carried out on 150 married females who were interviewed to answer Female Sexual Function Index (FSFI) questionnaire and were divided into two groups: the first group included 100 female patients complaining of psoriasis (50 suffering from moderate psoriasis and 50 with severe psoriasis). The disease severity was graded according to the Psoriasis Area and Severity Index (PASI) while the second group included 50 age matched women who served as controls. Female sexual dysfunction (FSD) in psoriasis female groups was higher than that in the control group (47%, 24%, P < 0.05). The mean total scores of FSFI ranged from 12.30 to 34.20 and were significantly lower in the severe PASI affected group (22.34 ± 5.35) when compared to moderate PASI group (26.24 ± 2.67) or control group (28.79 ± 2.22). In addition, total scores were significantly lower among moderate PASI affected females when compared to control group. Sexual dysfunction should be routinely investigated in female patients with psoriasis in the case of moderate-severe disease due to its negative impact on quality of life. Further research over the effect of certain interventional programs on FSD should be considered for patients suffering from psoriasis.

Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases.

Laparoendoscopic single-site surgery (LESS) has become a novel minimally invasive approach applied as an option to perform hysterectomy. The aim of the study was to evaluate the influence of LESS hysterectomy on the sexual function in women with benign gynecologic indications. From October 2016 to May 2021, a total of 486 premenopausal, sexually active women were eligible. Female sexual function index (FSFI) was used to assess sexual function preoperatively and 6, 12 months postoperatively. Total FSFI score ≤26.55 indicated female sexual dysfunction (FSD). Compared with pre-operation, each subdomain and total FSFI scores increased at 6 (all p < 0.05) and 12 months (all p < 0.001). Prevalence of FSD decreased at 6 (30 vs 39.9%, p = 0.002) and 12 months (27 vs 39.9%, p < 0.001). In patients with preoperative FSD, each subdomain and total FSFI scores improved at 6 and 12 months (all p < 0.001), while decreased at 6 months (p < 0.001) and had no significant difference at 12 months (p = 0.54) in patients without preoperative FSD. These results suggest that LESS hysterectomy has a significant positive effect on the sexual function in women with benign gynecologic diseases, especially those with preoperative FSD.

Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis.

Sexual dysfunction is a common disorder among women, especially during menopause. Metabolic syndrome is a multifactorial disease that, according to previous studies, there is a relationship between the metabolic syndrome and sexual dysfunction among women. The aim of this systematic review and meta-analysis is to obtain the prevalence of Female Sexual Dysfunction (FSD) among women with metabolic syndrome, and to analyze available related evidence. In this systematic review and meta-analysis, the keywords of MeSH, female sexual dysfunction, FSD, metabolic syndrome were searched in PubMed, Web of Science, Scopus, Science Direct and Google Scholar. The searches were conducted without a lower time limit and until May 2022. The prevalence of FSD among women with metabolic syndrome was found to be 39.3% (95% CI: 28.3-51.5). In the subgroup analysis and in the review of 4 studies, the prevalence of sexual dysfunction in postmenopausal women with metabolic syndrome was 49.8% (95% CI: 26.1-73.6). Analyzing the results of the meta-regression test in examining the effect of the three factors of sample size, year of the study, age, and BMI of the patients on the heterogeneity of the meta-analysis, showed that with the increase of the sample size, the prevalence of sexual dysfunction among women with metabolic syndrome decreases (p < 0.05). Moreover, the prevalence of sexual dysfunction among women with metabolic syndrome increases (p < 0.05) with the increase in the years of conducting studies and the mean of age of women with metabolic syndrome. Also, with increasing mean of BMI of female patients with metabolic syndrome, the prevalence of sexual dysfunction in these women also increases (p < 0.05). Female sexual dysfunction is a global health problem that can affect women's life to a great extent. Metabolic syndrome, which is a set of factors such as obesity, high blood pressure, and diabetes, affects sexual dysfunction in women. From this study, it can be concluded that there is a close relationship between metabolic syndrome and female sexual dysfunction.

Association of perceived male sexual dysfunction and sexually transmitted disease to female sexual function among Indonesian women

BACKGROUND Male sexual dysfunction (MSD)’s impact on female partners is challenging to understand. Male erectile dysfunction (ED) and ejaculation disorder likely affect female sexual function. This study aimed to examine the prevalence of female sexual dysfunction and disorder as well as the relationship between perceived MSD and female sexual function using the validated Indonesian short version of the 6-item Female Sexual Function Index (FSFI-6).&#x0D; METHODS This cross-sectional study was conducted at Cipto Mangunkusumo Hospital, Jakarta, Indonesia, from February 2018 to February 2019. About 702 Indonesian married women, including patients, visitors, and medical and nonmedical staff, provided the sociodemographic, FSFI-6, quality of life, and sexual function (ED, ejaculation disorder, and desire problems), and sexually transmitted disease (STD) data. The association between categorical variables was evaluated using Fisher’s test. Logistic regression was used for multivariate analysis, and a p-value of 0.05 was considered statistically significant.&#x0D; RESULTS Among 702 women, about 242 had sexual dysfunction (34.5%), 20 had sexual disorder (2.8%), 172 had low desire (24.5%), 72 had low arousal (10.3%), 253 had orgasmic function (36.0%), and 575 had sexual pain (81.9%). The respondents reported their partners’ STD, desire problems, ED, and ejaculation disorder. Female sexual disorder and low desire were associated with perceived ED. Female sexual disorder was associated with STD (Wald = 10.3, p = 0.001) and desire problems (Wald = 6.89, p = 0.008). No other MSD was associated with female sexual function.&#x0D; CONCLUSIONS Perceived STD and male desire problems affected female sexual disorder.

Prevalence and factors associated with sexual dysfunction in brazilian women: a cross-sectional study.

Changes in the mechanisms that modulate sexual response can contribute to the development of female sexual dysfunction (FSD). Although the prevalence of FSD in Brazil has been established, its associated risk factors have not been thoroughly examined. This study aimed to determine the prevalence of FSD in Brazilian women and identify any factors that may be associated with its presence. This study used a cross-sectional design and included women aged 18 years or older who had engaged in sexual activity within the past four weeks. Participants completed the Female Sexual Function Index (FSFI) and a sociodemographic and health questionnaire. Two groups were created based on FSFI scores: those with risk for FSD (score >26.55) and those without. The study used t-tests for independent samples to compare quantitative variables between the groups, and the chi-squared test, to compare categorical variables. Binomial logistic regression was used to test the association between sociodemographic and health variables and FSD. FSD had a prevalence of 31.7% (95% CI: 28.2%-35.5%). The results indicated that practice of physical activity was inversely associated with FSD (OR: 0.64, 95% CI: 0.45-0.92), whereas urinary incontinence (OR: 2.55, 95% CI: 1.68-3.87) and post-menopause (OR: 4.69, 95% CI: 1.66-13.3) were directly associated with FSD. A high prevalence of FSD was observed among Brazilian women in this study. Physically active women are less likely to have FSD. Menopause and the presence of urinary incontinence can negatively impact female sexual function.

(122) Provider Attitude towards Postpartum Sexual Health

Abstract Introduction The prevalence of female sexual dysfunction (FSD) worldwide is estimated to be 41% and is even more prevalent in postpartum patients. There are significant barriers to addressing FSD in a busy clinic and the use of a standardized screening questionnaire could be implemented to improve outcomes during postpartum appointments. Objective To assess provider knowledge and practices towards postpartum sexual health with the goal of improving postpartum sexual health. Methods Providers who care for postpartum patients at [institution and city obscured], were asked to complete an anonymous survey online to assess providers’ general knowledge and practices. Results 79% of respondents answered that they felt very comfortable assessing postpartum sexual health and 88% expressed a need for continuing education on sexual medicine. The most common response for barriers to care was a lack of time. None of the respondents reported using questionnaires to assess sexual health. Conclusions The most significant barriers to assessing postpartum sexual health are a lack of time and provider knowledge. To overcome this, a standardized questionnaire should be created and improved continuing education should be implemented. Disclosure No

(531) Effect of COVID- 19 on Sexual Function and Activities Among Women of Reproductive Age

Abstract Introduction The novel SARS corona virus (SARS COV 2) causing the Corona Virus Disease (COVID--19) was first reported in Wuhan, China in 2019 and became a global pandemic in 2020 with severe health and economic consequences forcing nations to declare nationwide lockdown to limit the ragging pandemic. Different patterns of signs and symptoms as well as complications were reported to have followed COVID-19. Objective The objectives of the study were to describe the prevalence of female sexual dysfunction and pattern of dysfunction and to determine the effect of COVID--19 infection pandemic and lockdown on sexual function and activities among women reproductive age. Methods This was a cross sectional study of women in the reproductive age-group evaluating the sexual health function before, during and after the COVID--19 infection pandemic and lockdown. This was assessed using a structured questionnaire and a modified Female Sexual Function Index (FSFI). A pre-tested interviewer administered questionnaire was administered to 203 women participants and the information collected included socio-demographic and gynaecologic characteristics, COVID--19 experiences, sexual history and function before, during and after the COVID--19 pandemic lockdown. Results Most of the respondents were aged between 20 and 50 years (95%), married (77.7%) and were sexually active at the time of the study (92.6%) and 16.3% of the respondents had COVID-19 infection at least once. Only 43.6% of the sexually active respondents currently have normal overall female sexual function score with the mean FSFI score of 24.5. 71.4% had at least mild hyposexual desire, 54.2% with arousal disorder, 32.1% disorders of lubrication, 43.3% have orgasm related dysfunction, 37.8% have sexual satisfaction related dysfunction and 41.1% have disorders of sexual pain. COVID-19 lockdown may have had effect on sexual activities as 11.3% of respondents were not sexually active before the lockdown, 13.3% during the lockdown whereas only 7.4% after the lockdown suggesting abstinence as a result of the lockdown. Among the sexually active respondents during COVID-19 lockdown mean FSFI score of 23.76 and only 36.9% had normal overall FSFI score. Conclusions Female sexual dysfunction is still prevalent with the most common form being disorders of desire and arousal. COVID-19 lockdown resulted in abstinence from sexual intercourse in some women and sexual function also noted to be reduced among the sexually active women with higher incidence of female sexual dysfunction during the lockdown. Disclosure No